CD44 and breast carcinoma: Additionally, the IL-6-induced CD44+ cells exhibited increased resistance to radiation (Fig. 2D), and reduced cell death after doxorubicin treatment (Fig. 2E) compared with CD44− cells, which was consistent with the characteristics of breast cancer stem cells (BrCSCs) reported in previous studies (15,16).